Telemedicine and remote rehabilitation for cardiac patients in the post COVID-19 era
ABSTRACT
Background:
The COVID-19 pandemic has accelerated the changes of daily practice in medical care worldwide. Telemedicine is one of the most stimulated field of this changes even in the cardiovascular disease care. In the past decade, remote monitoring has become important tools that provides valuable clinical information with respiratory assist devices as well as with implantable pacemakers from patients at home.
Objective:
To investigate whether these remote monitoring approaches could expand broader spectrum of cardiac disease patients with the development of non-invasive monitoring device.
Methods:
Several pilot studies of telemedicine-based monitoring system using commercially available digital device were conducted in the Infectious Disease Wards as well as other clinical setting during the COVID-19 pandemic. We evaluated the effectiveness of a remote heart monitoring system which provides real-time ECG and other vital signs in cardiovascular disease patients. Newly developed remote cardiac rehabilitation system is also evaluated.
Results:
We found that current remote monitoring technology could provide a sufficient vital sign that suggested a potential to predict a worsening of heart failure in advance. Remote cardiac rehabilitation could be effectively as well as safely provided in low to middle risk patients.
Conclusions:
Telemedicine and remote cardiac rehabilitation possess a great potential in the cardiovascular disease practice post COVID-19 era, however, there are several unsolved issues regarding their implementation into the real world clinical practice.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.